CIPHER Oncology Pvt. Ltd
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
CIPHER Oncology Pvt. Ltd - overview
Established
2019
Location
Hyderabad, Telangana, India
Primary Industry
Healthcare
About
Based in India, CIPHER Oncology Pvt. Ltd specializes in comprehensive cancer treatment services, delivering a blend of medical, surgical, and radiation oncology with personalized care tailored to the needs of cancer patients across the country. CIPHER Oncology Pvt. Ltd operates as a provider of oncology services, focusing on various cancer treatments.
Founded in 2019 in Hyderabad, India, the company has engaged in three funding deals, with its latest round occurring in June 2022. The company raised INR 117. 92 million from InHealth Ventures and M Venture Partners. The founder, Sasi Sunkara, has prior experience in the healthcare sector, contributing to the clinic's establishment and operational strategies.
The company currently has an estimated valuation of INR 1241. 71 million. CIPHER Oncology Pvt. Ltd offers a comprehensive suite of oncology services, including medical oncology, surgical oncology, and radiation therapy.
Their services are complemented by integrative care options such as genetic counseling and nutritional consultation. Utilizing advanced diagnostic technologies, including Digital PET-CT and MRI scans, the clinic provides tailored treatment strategies aimed at a diverse patient demographic across Telangana and Andhra Pradesh. The organization emphasizes personalized care to enhance the treatment journey for every individual diagnosed with cancer. In the most recent financial year of 2023, CIPHER Oncology Pvt.
Ltd reported a revenue of INR 600,765. 70 and an EBITDA of INR -788,860. 10. Revenue generation is structured around a service model that charges patients directly for consultations, diagnostic tests, and treatment services, ensuring transparency in transaction processes.
The company plans to utilize the INR 117. 92 million raised in June 2022 to expand its oncology services and possibly introduce new treatments in the near future. CIPHER Oncology Pvt. Ltd is targeting growth in new markets, specifically aiming to extend its reach beyond its current operational areas in Telangana and Andhra Pradesh.
Future initiatives may include launching additional service offerings and enhancing access to care for a wider patient base across India.
Current Investors
Natco Pharma Limited, Axilor Ventures, M Venture Partners
Primary Industry
Healthcare
Sub Industries
Clinics/Outpatient Services, Diagnostic, Medical & Imaging Laboratories, Hospitals, Oncology/Cancer Treatment
Website
www.cancerclinics.in
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.